DAIC

DECEMBER 14, 2023

This is the first PFA technology to receive FDA approval and follows the recent European CE (Conformité Européenne) Mark of the PulseSelect PFA system in November. This is the first PFA technology to receive FDA approval and follows the recent European CE (Conformité Européenne) Mark of the PulseSelect PFA system in November.

Atrial Fibrillation 105

Atrial Fibrillation Ablation Technology Risk Factors 105

DAIC

MAY 18, 2024

Recent technological advancements, such as catheter design and energy delivery, can pave the way for the wider adoption of PFA in clinical practice to improve patient outcomes. Pulmonary vein isolation (PVI) procedure, left atrial dwell, and fluoroscopy times were 51, 32, and 12 minutes, respectively.

Atrial Fibrillation 105

Atrial Fibrillation Heart Rhythm Ablation Quality of Life 105

DAIC

MARCH 20, 2024

He previously served on the AdvaMed Accel Board of Directors and as an observer on the Membership, Ethics and Technology and Regulatory committees of the AdvaMed Board. Billion by 2030 PECA Labs Achieves Successful First-In-Human Implant of the MASA Valve Pediatric Pulmonary Valved Conduit in U.S.

Pediatrics 105

Pediatrics Anatomy Technology Innovation 105

DAIC

DECEMBER 26, 2023

a company primarily focused on leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment of atrial fibrillation, announced the completion of the first five procedures in its first-in-human feasibility study with its novel CellFX nsPFA cardiac catheter.

Ablation 59

Ablation Atrial Fibrillation Technology Hospital 59

DAIC

MARCH 1, 2024

We have ways of preventing sudden cardiac arrest through technologies like a defibrillator, but the challenge is knowing who is most likely to benefit from this intervention,” said Lauri Holmstrom, MD, PhD, a visiting postdoctoral scientist at Cedars-Sinai and first author of both studies.

Cardiac Arrest 111

Cardiac Arrest Electrocardiogram Defibrillator Electrophysiology 111

DAIC

FEBRUARY 2, 2024

As Biosense Webster advances innovation for the treatment of AFib, we are thinking not only about new modalities of ablation, such as pulsed field ablation, but also how to make procedures safer, more effective and efficient. 2,3 Approximately 1 in 4 adults over the age of 40 are at risk for developing AFib.4

Ablation 105

Ablation Atrial Fibrillation AFIB Heart Rhythm 105

Cardiometabolic Health Congress

JULY 17, 2024

February 2024 FDA Approvals: Innovations in Cardiovascular Interventions XACT Carotid Stent System (Approved: 02/07/2024) This approval expands the indications to be used during a Transcarotid Artery Revascularization (TCAR) procedure to prevent future strokes.

Tricuspid 59

Tricuspid Open-Heart Surgery Kidney Disease Pediatrics 59

DAIC

MARCH 5, 2024

2** Furthermore, the primary effectiveness endpoint (PEE) of acute pulmonary vein isolation and 12-month freedom from atrial arrhythmia recurrence (AF, Atrial Tachycardia, or Atrial Flutter) was 75.6%. 4 “At Biosense Webster, we continually seek to push the boundaries of science and technology innovation in cardiac ablation.

Ablation 59

Ablation Atrial Fibrillation Atrial Flutter Pulmonary 59

CardiacWire

NOVEMBER 6, 2024

Cortex gives Boston Scientific a new mapping technology that detects AFib signs and triggers outside of the pulmonary veins, and can help EP teams develop ablation strategies for more complex AFib cases. for an undisclosed sum.

AFIB 105

AFIB Electrophysiology Ablation Technology 105

DAIC

OCTOBER 30, 2024

With this approval, Medtronic now offers two PFA technologies available for patients with Afib. We will continue to fulfill our commitment to innovation, including new indications, to advance cardiovascular care and improve patient outcomes." tim.hodson Wed, 10/30/2024 - 13:42 Oct. The potential of Affera is limitless.

Ablation 52

Ablation AFIB Atrial Fibrillation Atrial Flutter 52